Lulimac Lotion contains Luliconazole 1% w/v, a topical antifungal agent indicated for the treatment of various superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The lotion formulation allows for easy application and rapid absorption into the affected skin areas, providing targeted antifungal activity. Lulimac Lotion is typically applied once daily to the affected area and surrounding skin after cleansing and drying. Clinical studies have demonstrated its efficacy and safety in resolving fungal infections with a shorter duration of therapy compared to other topical antifungals. It is generally well tolerated, with minimal adverse effects such as mild local irritation or itching. Lulimac Lotion should be used as directed by a healthcare professional, avoiding contact with eyes and mucous membranes. Patients are advised to complete the full course of treatment to prevent recurrence and resistance. Use during pregnancy or lactation should be under medical supervision.